Telomerase and tumorigenesis

被引:53
作者
Masutomi, K
Hahn, WC
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
telomerase; telomerase reverse transcriptase (TERT); telomere; immortalization; human telomerase reverse transcriptase (hTERT); senescence; tumorigenesis; malignant transformation; cancer; telomere capping; tumor suppression; replication; mouse telomeres; tumor promotion; genomic instability; retinoblastoma; simian virus 40 (SV40); human papillomavirus;
D O I
10.1016/S0304-3835(02)00703-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The unique biology of telomeres and telomerase plays important roles in many aspects of mammalian cell physiology. Over the past decade, several lines of evidence have confirmed that the maintenance of telomeres and telomerase participate actively in the pathogenesis of human cancer. Specifically, activation of telomerase is strongly associated with cancer, and recent observations confirm that telomeres and telomerase perform important roles in both suppressing and facilitating malignant transformation by regulating genomic stability and cell lifespan, In addition, recent evidence suggests that telomerase activation contributes to tumorigenesis independently of its role in maintaining telomere length. Here we review recent developments in our understanding of the relationships among telomeres, telomerase, and cancer. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 112 条
[81]   DEVELOPMENTAL AND TISSUE-SPECIFIC REGULATION OF MOUSE TELOMERASE AND TELOMERE LENGTH [J].
PROWSE, KR ;
GREIDER, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4818-4822
[82]   Allosteric inhibitors of telomerase:: oligonucleotide N3′→P5′ phosphoramidates [J].
Pruzan, R ;
Pongracz, K ;
Gietzen, K ;
Wallweber, G ;
Gryaznov, S .
NUCLEIC ACIDS RESEARCH, 2002, 30 (02) :559-568
[83]  
Rich JN, 2001, CANCER RES, V61, P3556
[84]   Telomere dysfunction and evolution of intestinal carcinoma in mice and humans [J].
Rudolph, KL ;
Millard, M ;
Bosenberg, MW ;
DePinho, RA .
NATURE GENETICS, 2001, 28 (02) :155-159
[86]   SENESCENCE AS A MODE OF TUMOR SUPPRESSION [J].
SAGER, R .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1991, 93 :59-62
[87]   RESISTANCE OF HUMAN-CELLS TO TUMORIGENESIS INDUCED BY CLONED TRANSFORMING GENES [J].
SAGER, R ;
TANAKA, K ;
LAU, CC ;
EBINA, Y ;
ANISOWICZ, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (24) :7601-7605
[88]   Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang [J].
Samper, E ;
Goytisolo, FA ;
Slijepcevic, P ;
van Buul, PPW ;
Blasco, MA .
EMBO REPORTS, 2000, 1 (03) :244-252
[89]   Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells [J].
Saretzki, G ;
Ludwig, A ;
von Zglinicki, T ;
Runnebaum, IB .
CANCER GENE THERAPY, 2001, 8 (10) :827-834
[90]   Transformation of normal human cells in the absence of telomerase activation [J].
Seger, YR ;
García-Cao, M ;
Piccinin, S ;
Cunsolo, CL ;
Doglioni, C ;
Blasco, MA ;
Hannon, GJ ;
Maestro, R .
CANCER CELL, 2002, 2 (05) :401-413